Calpol 120mg/5ml Infant Oral Suspension

General Sale: Non-prescription

Company:
Kenvue
Status:
No Recent Update
Legal Category:
Supply through general sale
Active Ingredient(s):
Paracetamol
*Additional information is available within the SPC or upon request to the company

SPC
Patient Leaflets
Licence Info
Doc History

Licence number

Strength

ATC code

Dosage form

PA0330/017/001

120 mg/5ml

N02BE,N02BE01

Oral suspension

Brought to you by

About

Help
About
Contact Us

Legal

Privacy Statement
Terms & Conditions
Accessibility

Search

Medicines
Active Ingredients
Companies

Award

Direct Healthcare Professional Communications

The Summary of Product Characteristics (SPC) is a specific document, the wording of which has been agreed with the regulatory authority as part of the medicine approval process. It is required before any medicine is allowed on the market in Europe. It is designed to assist doctors and pharmacists in prescribing and supplying the product.

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

This medicine and its document have not been updated in the last 30 days.

''Company'' may refer to either the Marketing Authorization Holder (MAH), the company responsible for marketing the product in Ireland and/or responsible for uploading documents pertaining to the product onto Medicines.ie. To determine the MAH, please consult the actual submitted documents.

Calpol 120mg/5ml Infant Oral Suspension

Company:

Status:

Legal Category:

Active Ingredient(s):